{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:40:26Z","timestamp":1772858426687,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA DA000523-13"],"award-info":[{"award-number":["ZIA DA000523-13"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00213-022-06246-x","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T07:02:52Z","timestamp":1664780572000},"page":"3723-3730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reinforcing effects of phenethylamine analogs found in dietary supplements"],"prefix":"10.1007","volume":"239","author":[{"given":"Shelby A.","family":"McGriff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Chojnacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric B.","family":"Thorndike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-9116","authenticated-orcid":false,"given":"Charles W.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"6246_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0376-8716(98)00068-4","volume":"51","author":"SG Amara","year":"1998","unstructured":"Amara SG, Sonders MS (1998) Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 51:87\u201396","journal-title":"Drug Alcohol Depend"},{"key":"6246_CR2","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1097\/JSM.0000000000000842","volume":"31","author":"AN Amatto","year":"2021","unstructured":"Amatto AN, Amatto MD, Yu JC (2021) Preworkout supplement induced hemorrhagic stroke: a case report. Clin J Sport Med 31:e506\u2013e508","journal-title":"Clin J Sport Med"},{"key":"6246_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1124\/pr.115.011163","volume":"68","author":"JB Becker","year":"2016","unstructured":"Becker JB, Koob GF (2016) Sex differences in animal models: focus on addiction. Pharmacol Rev 68:242\u2013263","journal-title":"Pharmacol Rev"},{"key":"6246_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s002130100890","volume":"159","author":"J Bergman","year":"2001","unstructured":"Bergman J, Yasar S, Winger G (2001) Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. Psychopharmacology 159:21\u201330","journal-title":"Psychopharmacology"},{"key":"6246_CR5","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41386-021-00996-6","volume":"47","author":"SO Brown","year":"2022","unstructured":"Brown SO, Effinger DP, Montoro RA, Daddaoua N, Justinova Z, Moerke MJ, Schindler CW, Jedema HP, Bradberry CW (2022) Economic choice between remifentanil and food in squirrel monkeys. Neuropsychopharmacology 47:1398\u20131404","journal-title":"Neuropsychopharmacology"},{"key":"6246_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s002130050182","volume":"129","author":"ME Carroll","year":"1997","unstructured":"Carroll ME, Lac ST (1997) Acquisition of i.v. amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology 129:206\u2013214","journal-title":"Psychopharmacology"},{"key":"6246_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF00174364","volume":"89","author":"LD Chait","year":"1986","unstructured":"Chait LD, Uhlenhuth EH, Johanson CE (1986) The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology 89:301\u2013306","journal-title":"Psychopharmacology"},{"key":"6246_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/dta.1578","volume":"6","author":"PA Cohen","year":"2014","unstructured":"Cohen PA, Travis JC, Venhuis BJ (2014) A methamphetamine analog (N, alpha-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Test Anal 6:805\u2013807","journal-title":"Drug Test Anal"},{"key":"6246_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.7326\/L15-0106","volume":"162","author":"PA Cohen","year":"2015","unstructured":"Cohen PA, Zeijlon R, Nardin R, Keizers PH, Venhuis B (2015) Hemorrhagic stroke probably caused by exercise combined with a sports supplement containing beta-methylphenyl-ethylamine (BMPEA): a case report. Ann Intern Med 162:879\u2013880","journal-title":"Ann Intern Med"},{"key":"6246_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/dta.1793","volume":"8","author":"PA Cohen","year":"2016","unstructured":"Cohen PA, Bloszies C, Yee C, Gerona R (2016) An amphetamine isomer whose efficacy and safety in humans has never been studied, beta-methylphenylethylamine (BMPEA), is found in multiple dietary supplements. Drug Test Anal 8:328\u2013333","journal-title":"Drug Test Anal"},{"key":"6246_CR11","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/15563650.2021.1894333","volume":"59","author":"PA Cohen","year":"2021","unstructured":"Cohen PA, Travis JC, Vanhee C, Ohana D, Venhuis BJ (2021) Nine prohibited stimulants found in sports and weight loss supplements: deterenol, phenpromethamine (Vonedrine), oxilofrine, octodrine, beta-methylphenylethylamine (BMPEA), 1,3-dimethylamylamine (1,3-DMAA), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylbutylamine (1,3-DMBA) and higenamine. Clin Toxicol (phila) 59:975\u2013981","journal-title":"Clin Toxicol (phila)"},{"key":"6246_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF02805973","volume":"127","author":"SD Comer","year":"1996","unstructured":"Comer SD, Haney M, Foltin RW, Fischman MW (1996) Amphetamine self-administration by humans: modulation by contingencies associated with task performance. Psychopharmacology 127:39\u201346","journal-title":"Psychopharmacology"},{"key":"6246_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0376-8716(86)90068-2","volume":"16","author":"H de Wit","year":"1986","unstructured":"de Wit H, Uhlenhuth EH, Johanson CE (1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16:341\u2013360","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"6246_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","volume":"47","author":"G Di Chiara","year":"2004","unstructured":"Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47(Suppl 1):227\u2013241","journal-title":"Neuropharmacology"},{"key":"6246_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.52082\/jssm.2021.328","volume":"20","author":"E Duiven","year":"2021","unstructured":"Duiven E, van Loon LJC, Spruijt L, Koert W, de Hon OM (2021) Undeclared doping substances are highly prevalent in commercial sports nutrition supplements. J Sports Sci Med 20:328\u2013338","journal-title":"J Sports Sci Med"},{"key":"6246_CR16","doi-asserted-by":"crossref","unstructured":"Eichner S, Maguire M, Shea LA, Fete MG (2016) Banned and discouraged-use ingredients found in weight loss supplements. J Am Pharm Assoc 56:538\u2013543","DOI":"10.1016\/j.japh.2016.03.013"},{"key":"6246_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1744-9081-7-29","volume":"7","author":"AF Eisener-Dorman","year":"2011","unstructured":"Eisener-Dorman AF, Grabowski-Boase L, Tarantino LM (2011) Cocaine locomotor activation, sensitization and place preference in six inbred strains of mice. Behav Brain Funct 7:29","journal-title":"Behav Brain Funct"},{"key":"6246_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jat\/bkv022","volume":"39","author":"MA ElSohly","year":"2015","unstructured":"ElSohly MA, Murphy TP, ElSohly KM, Gul W (2015) LC-MS-MS Analysis of N, alpha-diethylphenethylamine (N, alpha-ETH) and its positional isomer N, beta-diethylphenethylamine (N, beta-ETH) in dietary supplements. J Anal Toxicol 39:387\u2013406","journal-title":"J Anal Toxicol"},{"key":"6246_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.physbeh.2017.11.017","volume":"203","author":"RJ Flores","year":"2019","unstructured":"Flores RJ, Uribe KP, Swalve N, O\u2019Dell LE (2019) Sex differences in nicotine intravenous self-administration: a meta-analytic review. Physiol Behav 203:42\u201350","journal-title":"Physiol Behav"},{"key":"6246_CR20","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","volume":"43","author":"BM Gannon","year":"2018","unstructured":"Gannon BM, Baumann MH, Walther D, Jimenez-Morigosa C, Sulima A, Rice KC, Collins GT (2018) The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter. Neuropsychopharmacology 43:2399\u20132407","journal-title":"Neuropsychopharmacology"},{"key":"6246_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00426841","volume":"50","author":"RR Griffiths","year":"1976","unstructured":"Griffiths RR, Winger G, Brady JV, Snell JD (1976) Comparison of behavior maintained by infusions of eight phenylethylamines in baboons. Psychopharmacology 50:251\u2013258","journal-title":"Psychopharmacology"},{"key":"6246_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","volume":"75","author":"LL Howell","year":"2008","unstructured":"Howell LL, Kimmel HL (2008) Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75:196\u2013217","journal-title":"Biochem Pharmacol"},{"key":"6246_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","volume":"14","author":"MJ Kuhar","year":"1991","unstructured":"Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299\u2013302","journal-title":"Trends Neurosci"},{"key":"6246_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1471-4159.2011.07335.x","volume":"118","author":"V Leviel","year":"2011","unstructured":"Leviel V (2011) Dopamine release mediated by the dopamine transporter, facts and consequences. J Neurochem 118:475\u2013489","journal-title":"J Neurochem"},{"key":"6246_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/pharmrev.121.000367","volume":"74","author":"C Nicolas","year":"2022","unstructured":"Nicolas C, Zlebnik NE, Farokhnia M, Leggio L, Ikemoto S, Shaham Y (2022) Sex differences in opioid and psychostimulant craving and relapse: a critical review. Pharmacol Rev 74:119\u2013140","journal-title":"Pharmacol Rev"},{"key":"6246_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0091-3057(91)90017-V","volume":"38","author":"R Oberlender","year":"1991","unstructured":"Oberlender R, Nichols DE (1991) Structural variation and (+)-amphetamine-like discriminative stimulus properties. Pharmacol Biochem Behav 38:581\u2013586","journal-title":"Pharmacol Biochem Behav"},{"key":"6246_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00213-007-0978-6","volume":"196","author":"LV Panlilio","year":"2008","unstructured":"Panlilio LV, Thorndike EB, Schindler CW (2008) A stimulus-control account of regulated drug intake in rats. Psychopharmacology 196:441\u2013450","journal-title":"Psychopharmacology"},{"key":"6246_CR28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/dta.1980","volume":"9","author":"RS Pawar","year":"2017","unstructured":"Pawar RS, Grundel E (2017) Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs). Drug Test Anal 9:500\u2013517","journal-title":"Drug Test Anal"},{"key":"6246_CR29","doi-asserted-by":"publisher","first-page":"172515","DOI":"10.1016\/j.ejphar.2019.172515","volume":"859","author":"A Rickli","year":"2019","unstructured":"Rickli A, Hoener MC, Liechti ME (2019) Pharmacological profiles of compounds in preworkout supplements (\u201cboosters\u201d). Eur J Pharmacol 859:172515","journal-title":"Eur J Pharmacol"},{"key":"6246_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0091-3057(77)90096-X","volume":"6","author":"ME Risner","year":"1977","unstructured":"Risner ME, Jones BE (1977) Characteristics of beta-phenethylamine self-administration by dog. Pharmacol Biochem Behav 6:689\u2013696","journal-title":"Pharmacol Biochem Behav"},{"key":"6246_CR31","first-page":"1220","volume":"291","author":"GJ Riviere","year":"1999","unstructured":"Riviere GJ, Byrnes KA, Gentry WB, Owens SM (1999) Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J Pharmacol Exp Ther 291:1220\u20131226","journal-title":"J Pharmacol Exp Ther"},{"key":"6246_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","volume":"479","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23\u201340","journal-title":"Eur J Pharmacol"},{"key":"6246_CR33","doi-asserted-by":"crossref","unstructured":"Runegaard AH, Sorensen AT, Fitzpatrick CM, Jorgensen SH, Petersen AV, Hansen NW, Weikop P, Andreasen JT, Mikkelsen JD, Perrier JF, Woldbye D, Rickhag M, Wortwein G, Gether U (2018) Locomotor- and reward-enhancing effects of cocaine are differentially regulated by chemogenetic stimulation of Gi-signaling in dopaminergic neurons. eNeuro 5:ENEURO.0345-17.2018","DOI":"10.1523\/ENEURO.0345-17.2018"},{"key":"6246_CR34","doi-asserted-by":"crossref","unstructured":"Ryu IS, Kim OH, Kim JS, Sohn S, Choe ES, Lim RN, Kim TW, Seo JW, Jang EY (2021) Effects of beta-phenylethylamine on psychomotor, rewarding, and reinforcing behaviors and affective state: the role of dopamine D1 receptors. Int J Mol Sci 22:9485","DOI":"10.3390\/ijms22179485"},{"key":"6246_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.fct.2014.10.009","volume":"74","author":"MF Santillo","year":"2014","unstructured":"Santillo MF (2014) Inhibition of monoamine oxidase (MAO) by alpha-ethylphenethylamine and N, alpha-diethylphenethylamine, two compounds related to dietary supplements. Food Chem Toxicol 74:265\u2013269","journal-title":"Food Chem Toxicol"},{"key":"6246_CR36","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","volume":"233","author":"CW Schindler","year":"2016","unstructured":"Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD, Baumann MH (2016) Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233:1981\u20131990","journal-title":"Psychopharmacology"},{"key":"6246_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.118.255976","volume":"369","author":"CW Schindler","year":"2019","unstructured":"Schindler CW, Thorndike EB, Rice KC, Partilla JS, Baumann MH (2019) The supplement adulterant beta-methylphenethylamine increases blood pressure by acting at peripheral norepinephrine transporters. J Pharmacol Exp Ther 369:328\u2013336","journal-title":"J Pharmacol Exp Ther"},{"key":"6246_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1124\/jpet.120.000129","volume":"376","author":"CW Schindler","year":"2021","unstructured":"Schindler CW, Thorndike EB, Partilla JS, Rice KC, Baumann MH (2021) Amphetamine-like neurochemical and cardiovascular effects of alpha-ethylphenethylamine analogs found in dietary supplements. J Pharmacol Exp Ther 376:118\u2013126","journal-title":"J Pharmacol Exp Ther"},{"key":"6246_CR39","doi-asserted-by":"publisher","first-page":"109299","DOI":"10.1016\/j.drugalcdep.2022.109299","volume":"232","author":"RW Seaman Jr","year":"2022","unstructured":"Seaman RW Jr, Rice KC, Collins GT (2022) Relative reinforcing effects of cocaine and 3,4-methylenedioxypyrovalerone (MDPV) under a concurrent access self-administration procedure in rats. Drug Alcohol Depend 232:109299","journal-title":"Drug Alcohol Depend"},{"key":"6246_CR40","first-page":"52","volume":"222","author":"HE Shannon","year":"1982","unstructured":"Shannon HE, Degregorio CM (1982) Self-administration of the endogenous trace amines beta-phenylethylamine, N-methyl phenylethylamine and phenylethanolamine in dogs. J Pharmacol Exp Ther 222:52\u201360","journal-title":"J Pharmacol Exp Ther"},{"key":"6246_CR41","first-page":"691","volume":"228","author":"HE Shannon","year":"1984","unstructured":"Shannon HE, Thompson WA (1984) Behavior maintained under fixed-interval and second-order schedules by intravenous injections of endogenous noncatecholic phenylethylamines in dogs. J Pharmacol Exp Ther 228:691\u2013695","journal-title":"J Pharmacol Exp Ther"},{"key":"6246_CR42","first-page":"190","volume":"223","author":"HE Shannon","year":"1982","unstructured":"Shannon HE, Cone EJ, Yousefnejad D (1982) Physiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dog. J Pharmacol Exp Ther 223:190\u2013196","journal-title":"J Pharmacol Exp Ther"},{"key":"6246_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1037\/a0024798","volume":"19","author":"M Thomsen","year":"2011","unstructured":"Thomsen M, Caine SB (2011) Psychomotor stimulant effects of cocaine in rats and 15 mouse strains. Exp Clin Psychopharmacol 19:321\u2013341","journal-title":"Exp Clin Psychopharmacol"},{"key":"6246_CR44","doi-asserted-by":"publisher","first-page":"173255","DOI":"10.1016\/j.pbb.2021.173255","volume":"209","author":"EB Towers","year":"2021","unstructured":"Towers EB, Lynch WJ (2021) The importance of examining sex differences in animal models validated to induce an addiction-like phenotype. Pharmacol Biochem Behav 209:173255","journal-title":"Pharmacol Biochem Behav"},{"key":"6246_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0006-8993(99)01717-5","volume":"839","author":"VL Tsibulsky","year":"1999","unstructured":"Tsibulsky VL, Norman AB (1999) Satiety threshold: a quantitative model of maintained cocaine self-administration. Brain Res 839:85\u201393","journal-title":"Brain Res"},{"key":"6246_CR46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pbb.2006.05.022","volume":"84","author":"S Wee","year":"2006","unstructured":"Wee S, Woolverton WL (2006) Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys. Pharmacol Biochem Behav 84:337\u2013343","journal-title":"Pharmacol Biochem Behav"},{"key":"6246_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF00496868","volume":"48","author":"RA Yokel","year":"1976","unstructured":"Yokel RA, Wise RA (1976) Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48:311\u2013318","journal-title":"Psychopharmacology"},{"key":"6246_CR48","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s10068-017-0176-1","volume":"26","author":"J Yun","year":"2017","unstructured":"Yun J, Kwon K, Choi J, Jo CH (2017) Monitoring of the amphetamine-like substances in dietary supplements by LC-PDA and LC-MS\/MS. Food Sci Biotechnol 26:1185\u20131190","journal-title":"Food Sci Biotechnol"},{"key":"6246_CR49","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpba.2018.01.025","volume":"151","author":"J Zhao","year":"2018","unstructured":"Zhao J, Wang M, Avula B, Khan IA (2018) Detection and quantification of phenethylamines in sports dietary supplements by NMR approach. J Pharm Biomed Anal 151:347\u2013355","journal-title":"J Pharm Biomed Anal"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06246-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06246-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06246-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T06:04:29Z","timestamp":1666245869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06246-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6246"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06246-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"8 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}